Ten months after Pfizer scored approval in Europe for Emblaveo (aztreonam and avibactam) to treat complicated intra-abdominal infections (cIAIs), AbbVie has done the same in the U.S., ...

AbbVie has claimed FDA approval for Emblaveo, a new antibiotic product to treat complicated intra-abdominal infections (cIAI) ...

In this one, the researchers discovered that coffee drinking correlated with an increase in several bacterial species, but ...

A study reveals alarming rates of antibiotic resistance in Gram-negative bacteria, highlighting the urgent need for ...

Clothes and fishing nets that are made of nylon often end up in landfill or dumped in oceans, but a new way to break down the ...

AbbVie has received US FDA approval for Emblaveo to be used in conjunction with metronidazole for individuals with cIAI.

AbbVie receives US FDA approval for Emblaveo to treat adults with complicated intra-abdominal infections with limited or no treatment options: North Chicago, Illinois Monday, Febr ...

Nanotube bridge networks grow between the most abundant photosynthetic bacteria in the oceans, suggesting that the world is ...

Bacteria could be the answer to living solar panels that harness the power of the sun for homes in the future. Here's how ...

A new study has found that going on a juice-only diet for as little as three days can change people’s oral microbiome, with ...

Harvard researchers have found that M. morganii may contribute to depression by producing an inflammatory molecule.